HUNTSMAN CAROLE (Chief Commercial Officer) sold 9.1% of their position (910.00 shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $449.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/26/2026ACC: 0001628280-26-003482
Officer· Chief Commercial Officer
Since Mar 2026
-910.00
Net shares
Net seller
$449.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
910.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−340.00
Price / share
$492.42
Trade value
$167.42K
% of position
3.4%
1/26/2026
10.03K→9.69K
Common Stock
Direct
Shares
−570.00
Price / share
$494.59
Trade value
$281.92K
% of position
5.9%
1/26/2026
9.69K→9.12K
Total
Net shares
−910.00
Net value
-$449.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/26/2026 | S · Sale | −340.00 | $492.42 | $167.42K | 3.4% | 10.03K | 9.69K |
| Common Stock Direct | 1/26/2026 | S · Sale | −570.00 | $494.59 | $281.92K | 5.9% | 9.69K | 9.12K |
| Total | −910.00 | -$449.34K | ||||||
Derivative Transactions0
No derivative transactions reported